a statistical trendp = 0.06
These data match the fact that WM983BR had a decreased but not significant tumor volume with trametinib treatment during our observation period, showing only a statistical trend ( p = 0.06, Figure 7 ).
These data match the fact that WM983BR had a decreased but not significant tumor volume with trametinib treatment during our observation period, showing only a statistical trend ( p = 0.06, Figure 7 ).
Furthermore, the time-related differences in the tumor lactate and alanine content between the untreated and trametinib-treated groups in the WM983BR, WM983B, and DB-1 xenografts were highly significant (slope comparison p -value in Figure 5 ).